Vis, Jeroen C <br/><br/>
Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease.  [electronic resource] 

 -  International journal of cardiology  Mar 2013 
 - 64-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1874-1754 
<br/><br/><label>Standard No.: </label>10.1016/j.ijcard.2011.06.064  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antihypertensive Agents--therapeutic use<br/>Bosentan<br/>Down Syndrome--complications<br/>Familial Primary Pulmonary Hypertension<br/>Female<br/>Heart Defects, Congenital--complications<br/>Humans<br/>Hypertension, Pulmonary--complications<br/>Male<br/>Middle Aged<br/>Sulfonamides--therapeutic use<br/>Survival Rate<br/>Time Factors